 Long-lasting depression factor XII-dependent fibrinolytic system patients myocardial infarction thrombolytic therapy recombinant tissue-type plasminogen activator randomized placebo-controlled study randomized placebo-controlled study patients acute myocardial infarction intravenous treatment mg recombinant tissue-type plasminogen activator rt-PA patients periods treatment Seven patients acute myocardial infarction streptokinase periods treatment placebo group significant deviations endogenous factor XII-dependent fibrinolytic activity rt-PA group activity infusion days significant decrease activity streptokinase-treated patients depletion factor XII-dependent fibrinolytic activity due generation inhibition depletion factor XII prekallikrein plasminogen proactivator system rt-PA streptokinase treatment patients acute myocardial infarction prolonged depletion factor XII-dependent fibrinolytic activity depression endogenous fibrinolytic activity relation risk coronary reocclusion thrombolytic therapy